Cisatracurium Besylate Injection
Product Images NDC 65145-137

13 FDA label images from Caplin Steriles Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 65145-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisatracurium-besylate-structure (Cisatracurium Besylate Structure)

Cisatracurium-besylate-structure (Cisatracurium Besylate Structure)
Chemical structure diagram of Cisatracurium besylate showing its molecular components with detailed arrangements of atoms and bonds including multiple methoxy groups and benzene rings.*
FDA Label Image

Cisatracurium-besylate-figure-1 (Cisatracurium Besylate Figure 1)

Cisatracurium-besylate-figure-1 (Cisatracurium Besylate Figure 1)
A scatter plot with percent change on both axes, showing data points clustered near the center. The vertical axis is labeled 'HR' with a range from -60% to +60%, and the horizontal axis is labeled 'MAP' with a similar range. The plot visualizes variability or correlation between heart rate (HR) and mean arterial pressure (MAP).*
FDA Label Image

Cisatracurium-besylate-figure-2 (Cisatracurium Besylate Figure 2)

Cisatracurium-besylate-figure-2 (Cisatracurium Besylate Figure 2)
A scatter plot depicting the relationship between heart rate (HR) and mean arterial pressure (MAP) percentage changes, ranging from -60% to +60% on both axes. Several black dots are clustered near the center, indicating data points around no change in HR and MAP.*
FDA Label Image
FDA Label Image

Cisatracurium-besylate-carton1-5ml (Cisatracurium Besylate Carton1 5ml)

Cisatracurium-besylate-carton1-5ml (Cisatracurium Besylate Carton1 5ml)
Packaging label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) for intravenous injection. The label states it is preservative free and contains 10 x 5 mL single-dose vials. The label includes a warning that the drug is a paralyzing agent causing respiratory arrest, with storage instructions to keep refrigerated at 2° to 8°C in the carton. The labeler is Caplin Steriles Limited.*
FDA Label Image

Cisatracurium-besylate-carton2-5ml (Cisatracurium Besylate Carton2 5ml)

Cisatracurium-besylate-carton2-5ml (Cisatracurium Besylate Carton2 5ml)
Packaging label for Cisatracurium Besylate Injection, USP, 10 mg per 5 mL (2 mg/mL) for intravenous use. The label indicates the product is preservative-free, a paralyzing agent, and is supplied in 10 single-dose vials of 5 mL each. Distributed by Caplin Steriles USA Inc, made in India.*
FDA Label Image

Cisatracurium-besylate-carton1-10ml (Cisatracurium Besylate Carton1 10ml)

Cisatracurium-besylate-carton1-10ml (Cisatracurium Besylate Carton1 10ml)
Packaging label for Cisatracurium Besylate Injection, USP, 2 mg/mL strength, in 10 mL multiple-dose vials, distributed by Caplin Steriles Limited. The label indicates it is for intravenous injection, includes 0.9% benzyl alcohol as a preservative, and carries a warning that it is a paralyzing agent causing respiratory arrest. Storage instructions and batch overprinting area are also noted.*
FDA Label Image

Cisatracurium-besylate-carton2-10ml (Cisatracurium Besylate Carton2 10ml)

Cisatracurium-besylate-carton2-10ml (Cisatracurium Besylate Carton2 10ml)
Packaging label for Cisatracurium Besylate Injection, USP, 20 mg/10 mL (2 mg/mL) intravenous injection by Caplin Steriles. The label indicates multiple-dose vials containing 10 x 10 mL with 0.9% benzyl alcohol as a preservative. Distributed by Caplin Steriles USA Inc.*
FDA Label Image

Cisatracurium-besylate-carton-20ml (Cisatracurium Besylate Carton 20ml)

Cisatracurium-besylate-carton-20ml (Cisatracurium Besylate Carton 20ml)
Packaging label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) intravenous injection by Caplin Steriles Limited. The label highlights it as a preservative-free, single-dose vial for ICU use only with warnings about its paralyzing effects and the need for artificial respiration facilities. Storage instructions and manufacturer details are included.*
FDA Label Image

Cisatracurium-besylate-vial-5ml (Cisatracurium Besylate Vial 5ml)

Cisatracurium-besylate-vial-5ml (Cisatracurium Besylate Vial 5ml)
Label for Cisatracurium Besylate Injection, USP, 10 mg/5 mL (2 mg/mL) preservative-free intravenous injection. The label includes a warning that it is a paralyzing agent causing respiratory arrest and must be used where artificial respiration is immediately available. It is a 5 mL single-dose vial manufactured by Caplin Steriles Limited, India, with storage instructions to keep refrigerated between 2° to 8°C.*
FDA Label Image

Cisatracurium-besylate-vial-10ml (Cisatracurium Besylate Vial 10ml)

Cisatracurium-besylate-vial-10ml (Cisatracurium Besylate Vial 10ml)
Label for Cisatracurium Besylate Injection USP, 2 mg/mL (20 mg/10 mL) in a 10 mL multiple-dose vial. It is indicated for intravenous injection and contains 0.9% benzyl alcohol as a preservative. The label includes a warning about the drug's paralytic effects and storage instructions. Manufactured by Caplin Steriles Limited, India.*
FDA Label Image

Cisatracurium-besylate-vial-20ml (Cisatracurium Besylate Vial 20ml)

Cisatracurium-besylate-vial-20ml (Cisatracurium Besylate Vial 20ml)
Label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL), a paralyzing agent indicated for ICU use. It is for intravenous injection in a 20 mL single-dose vial, labeled with warnings about respiratory arrest and instructions for storage at 2° to 8°C. Manufactured by Caplin Steriles Limited, India.*
FDA Label Image

Cisatracurium-besylate-sticker-label (Cisatracurium Besylate Sticker Label)

Cisatracurium-besylate-sticker-label (Cisatracurium Besylate Sticker Label)
Label for Cisatracurium Besylate Injection, USP. The label prominently displays a warning stating the drug is a paralyzing agent that causes respiratory arrest. A blank space is provided for indicating the concentration in mg/mL. The label has a red background with white text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.